Who has invested in Aera Therapeutics?

ARCH Venture Partners, GV, Lux Capital are named among the investors backing Aera Therapeutics.

Aera Therapeutics Funding: $193M Raised, Series B (2023)

Aera Therapeutics funding overview

Aera Therapeutics is based in Cambridge, Massachusetts. Aera Therapeutics has raised $193M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2023. The round record for Aera Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, GV, Lux Capital. 3 distinct backers are named across the disclosed rounds.

Aera Therapeutics at a glance

Total raised: $193M
Latest round: Series B
Latest round date: February 2023
Headquarters: Cambridge, Massachusetts
Notable investors: ARCH Venture Partners, GV, Lux Capital

Frequently asked about Aera Therapeutics funding

How much has Aera Therapeutics raised?: Aera Therapeutics has raised $193M in total disclosed funding across the rounds on record.
Who has invested in Aera Therapeutics?: ARCH Venture Partners, GV, Lux Capital are named among the investors backing Aera Therapeutics.
What was the latest Aera Therapeutics funding round?: The most recent disclosed round is a Series B, announced in February 2023.
Where is Aera Therapeutics based?: Aera Therapeutics is based in Cambridge, Massachusetts.
When did Aera Therapeutics last raise?: The last disclosed Aera Therapeutics round closed in February 2023 at Series B.

Round data for Aera Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Aera Therapeutics Funding: $193M Raised, Series B (2023)

Aera Therapeutics funding overview

Aera Therapeutics at a glance

Frequently asked about Aera Therapeutics funding

Companies related to Aera Therapeutics (35)

Browse related funding lists (7)